Kombinovane oralne kontraceptivne tablete (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kombinovane oralne kontraceptivne tablete" in Serbian language version.

refsWebsite

Global rank Serbian rank

6nih.gov

4^th place

8^th place

5web.archive.org

1^st place

5doi.org

2^nd place

4^th place

1worldcat.org

5^th place

12^th place

1contraceptivetechnology.org

low place

1iarc.fr

4,025^th place

2,629^th place

1maastrichtuniversity.nl

low place

1archive.org

6^th place

5^th place

1plannedparenthood.org

low place

1cdc.gov

218^th place

138^th place

1guttmacher.org

9,659^th place

low place

1un.org

97^th place

49^th place

1netdoctor.co.uk

9,484^th place

7,445^th place

1nationalarchives.gov.uk

744^th place

1,791^st place

1statistics.gov.uk

1,258^th place

4,448^th place

1who.int

195^th place

154^th place

1nytimes.com

7^th place

25^th place

1vasezdravlje.com

low place

4,426^th place

1novilist.hr

low place

881^st place

1oktal-pharma.hr

low place

1cybermed.hr

low place

8,493^rd place

archive.org

Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A (maj 2002). „Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke”. Stroke. 33 (5): 1202—8. PMID 11988591. doi:10.1161/01.STR.0000015345.61324.3F.

cdc.gov

Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ (decembar 2004). „Use of contraception and use of family planning services in the United States: 1982-2002” (PDF). Advance Data (350): 1—36. PMID 15633582. all US women aged 15–44

contraceptivetechnology.org

Trussell J (2011). „Contraceptive efficacy”. Ур.: Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS. Contraceptive technology (20th revised изд.). New York: Ardent Media. стр. 779—863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Архивирано на сајту Wayback Machine (15. фебруар 2017)

cybermed.hr

http://www.cybermed.hr/clanci/kontraindikacije_za_primjenu_oralnih_hormonskih_kontraceptiva_i_interakcija_s_lijekovima Mr. sc. Jasna Gobić Matejčić, dr. med., Klinika za ginekologiju i porodništvo KBC-a Rijeka, Zadnja izmjena: 27.12.2010. (pristupljeno 10. 5. 2013)

doi.org

Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ (mart 2010). „Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study”. BMJ. 340: c927. PMC 2837145 . PMID 20223876. doi:10.1136/bmj.c927.
Collaborative Group on Hormonal Factors in Breast Cancer (jun 1996). „Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies”. Lancet. 347 (9017): 1713—27. PMID 8656904. doi:10.1016/S0140-6736(96)90806-5. Архивирано из оригинала 23. 01. 2019. г. Приступљено 16. 02. 2019.
Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A (maj 2002). „Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke”. Stroke. 33 (5): 1202—8. PMID 11988591. doi:10.1161/01.STR.0000015345.61324.3F.
Baillargeon JP, McClish DK, Essah PA, Nestler JE (jul 2005). „Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis”. The Journal of Clinical Endocrinology and Metabolism. 90 (7): 3863—70. PMID 15814774. doi:10.1210/jc.2004-1958.
Yoshida H, Sakamoto H, Leslie A, Takahashi O, Tsuboi S, Kitamura K (jun 2016). „Contraception in Japan: Current trends”. Contraception. 93 (6): 475—7. PMID 26872717. doi:10.1016/j.contraception.2016.02.006.

guttmacher.org

„Contraceptive Use in the United States”. Guttmacher Institute. 4. 8. 2004. Приступљено 11. 12. 2016.

iarc.fr

monographs.iarc.fr

IARC working group (2007). „Combined Estrogen-Progestogen Contraceptives” (PDF). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 91.

maastrichtuniversity.nl

cris.maastrichtuniversity.nl

Collaborative Group on Hormonal Factors in Breast Cancer (jun 1996). „Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies”. Lancet. 347 (9017): 1713—27. PMID 8656904. doi:10.1016/S0140-6736(96)90806-5. Архивирано из оригинала 23. 01. 2019. г. Приступљено 16. 02. 2019.

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

Taylor T, Keyse L, Bryant A (2006). Contraception and Sexual Health, 2005/06 (PDF). London: Office for National Statistics. ISBN 978-1-85774-638-9. Архивирано из оригинала (PDF) 9. 1. 2007. г. British women aged 16–49: 24% currently use the pill (17% use Combined pill, 5% use Minipill, 2% don't know type)

netdoctor.co.uk

Delvin D (15. 6. 2016). „Contraception – the contraceptive pill: How many women take it in the UK?”. Архивирано из оригинала 04. 01. 2011. г. Приступљено 16. 02. 2019.

nih.gov

ncbi.nlm.nih.gov

Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ (mart 2010). „Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study”. BMJ. 340: c927. PMC 2837145 . PMID 20223876. doi:10.1136/bmj.c927.
Collaborative Group on Hormonal Factors in Breast Cancer (jun 1996). „Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies”. Lancet. 347 (9017): 1713—27. PMID 8656904. doi:10.1016/S0140-6736(96)90806-5. Архивирано из оригинала 23. 01. 2019. г. Приступљено 16. 02. 2019.
Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A (maj 2002). „Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke”. Stroke. 33 (5): 1202—8. PMID 11988591. doi:10.1161/01.STR.0000015345.61324.3F.
Baillargeon JP, McClish DK, Essah PA, Nestler JE (jul 2005). „Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis”. The Journal of Clinical Endocrinology and Metabolism. 90 (7): 3863—70. PMID 15814774. doi:10.1210/jc.2004-1958.
Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ (decembar 2004). „Use of contraception and use of family planning services in the United States: 1982-2002” (PDF). Advance Data (350): 1—36. PMID 15633582. all US women aged 15–44
Yoshida H, Sakamoto H, Leslie A, Takahashi O, Tsuboi S, Kitamura K (jun 2016). „Contraception in Japan: Current trends”. Contraception. 93 (6): 475—7. PMID 26872717. doi:10.1016/j.contraception.2016.02.006.

novilist.hr

http://www.novilist.hr/Lifestyle/Zdravlje-ljepota/Zdravlje/Francuska-ogranicava-kontraceptive-3.-i-4.-generacije-zbog-zdravstenih-rizika Autor: HINA, Objavljeno: 4. 1. 2013. (pristupljeno 10. 5. 2013)

nytimes.com

Harris G (3. 5. 2010). „The Pill Started More Than One Revolution”. The New York Times. Приступљено 21. 9. 2015.

oktal-pharma.hr

http://www.oktal-pharma.hr/hr/content/display/202/ Архивирано на сајту Wayback Machine (28. јун 2015) mr. sc. Sandra Kovačević, dr. med., spec. ginekologije i porodništva / objavljeno u broju 63 (prosinac 2008); 5. siječnja 2009. (pristupljeno 10. 5. 2013)

plannedparenthood.org

„Birth Control Pills - Birth Control Pill - The Pill”.

statistics.gov.uk

Taylor T, Keyse L, Bryant A (2006). Contraception and Sexual Health, 2005/06 (PDF). London: Office for National Statistics. ISBN 978-1-85774-638-9. Архивирано из оригинала (PDF) 9. 1. 2007. г. British women aged 16–49: 24% currently use the pill (17% use Combined pill, 5% use Minipill, 2% don't know type)

un.org

UN Population Division (2006). World Contraceptive Use 2005 (PDF). New York: United Nations. ISBN 978-92-1-151418-6. women aged 15–49 married or in consensual union

vasezdravlje.com

http://www.vasezdravlje.com/printable/izdanje/clanak/1872/ Архивирано на сајту Wayback Machine (24. јул 2017) mr. sc. Sandra Kovačević, dr. med., spec. ginekologije i porodništva, objavljeno u broju 70 (februar 2010) (pristupljeno 10. maja 2013)

web.archive.org

Trussell J (2011). „Contraceptive efficacy”. Ур.: Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS. Contraceptive technology (20th revised изд.). New York: Ardent Media. стр. 779—863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Архивирано на сајту Wayback Machine (15. фебруар 2017)
Collaborative Group on Hormonal Factors in Breast Cancer (jun 1996). „Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies”. Lancet. 347 (9017): 1713—27. PMID 8656904. doi:10.1016/S0140-6736(96)90806-5. Архивирано из оригинала 23. 01. 2019. г. Приступљено 16. 02. 2019.
Delvin D (15. 6. 2016). „Contraception – the contraceptive pill: How many women take it in the UK?”. Архивирано из оригинала 04. 01. 2011. г. Приступљено 16. 02. 2019.
http://www.vasezdravlje.com/printable/izdanje/clanak/1872/ Архивирано на сајту Wayback Machine (24. јул 2017) mr. sc. Sandra Kovačević, dr. med., spec. ginekologije i porodništva, objavljeno u broju 70 (februar 2010) (pristupljeno 10. maja 2013)
http://www.oktal-pharma.hr/hr/content/display/202/ Архивирано на сајту Wayback Machine (28. јун 2015) mr. sc. Sandra Kovačević, dr. med., spec. ginekologije i porodništva / objavljeno u broju 63 (prosinac 2008); 5. siječnja 2009. (pristupljeno 10. 5. 2013)

who.int

apps.who.int

„WHO Model List of EssentialMedicines” (PDF). World Health Organization. oktobar 2013. Приступљено 22. 4. 2014.

worldcat.org

Trussell J (2011). „Contraceptive efficacy”. Ур.: Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS. Contraceptive technology (20th revised изд.). New York: Ardent Media. стр. 779—863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Архивирано на сајту Wayback Machine (15. фебруар 2017)